Recognition of immune reconstitution syndrome necessary for better management of patients with severe drug eruptions and those under immunosuppressive therapy

Allergology International

Volumn 59, Issue 4, 2010, Pages 333-343

  Shiohara, Tetsuo ^a   Kurata, Maiko ^a   Mizukawa, Yoshiko ^a   Kano, Yoko ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Corticosteroids; Drug induced hypersensitivity syndrome; Herpesviruses; Immune reconstitution; Tnf a inhibitors

Indexed keywords

ANTIINFECTIVE AGENT; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ARTICLE; CRYPTOCOCCOSIS; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; DRESS SYNDROME; DRUG ERUPTION; GRAVES DISEASE; HASHIMOTO DISEASE; HEPATITIS B; HEPATITIS C; HERPES SIMPLEX; HERPES ZOSTER; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOSUPPRESSIVE TREATMENT; KAPOSI SARCOMA; PRIORITY JOURNAL; PROGNOSIS; SARCOIDOSIS; SYMPTOM; TUBERCULOSIS;

EID: 78650959615     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.10-RAI-0260     Document Type: Article

References (68)

1. Suzuki Y, Inagi R, Aono T, Yamanishi K, Shiohara T. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 1998;134:1108-12.
2. Shiohara T, Kano Y. A complex interaction between drug allergy and viral infection. Clin Rev Allergy Immunol 2007; 33:124-33
3. Smith KJ, Skelton HG, Yeager J, Ledsky R, Ng TH, Wagner KF. Increased drug reactions in HIV-1-positive patients: a possible explanation based on patterns of immune dysregulation seem in HIV-1 disease. Clin Exp Dermatol 1997;22:118-23
4. Miceli MH, Maertens J, Buvé K et al. Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: Proof of principle, description, and clinical and research implications. Cancer 2007;110:112-20
5. Legrand F, Lecuit M, Dupont B et al. Adjuvant corticosteroid therapy for chronic disseminated candidiasis. Clin Infect Dis 2008;46:696-702
6. Garcia Vidal C, Rodriguez Femández S, Martinez Lacasa J et al. Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis. Clin Infect Dis 2005;40:756-9
7. Arend SE, Leyten EM, Franken WP, Huisman EM, van Dissel JT. A patient with de novo tuberculosis during antitumor necrosis factor-alpha therapy illustrating diagnostic pitfalls and paradoxical response to treatment. Clin Infect Dis 2007;45:1470-5
8. Belknap R, Reves R, Burman W. Immune reconstitution to Mycobacterium tuberculosis after discontinuing infliximab. Int J Tuberc Lung Dis 2005;9:1057-8
9. Cheng VC, Yuen KY, Chan WM, Wong SS, Ma ES, Chan RM. Immunorestitution disease involving the innate and adaptive response. Clin Infect Dis 2000;30:882-92
10. Manabe YC, Campbell JD, Sydnor E, Moore RD. Immune reconstitution inflammatory syndrome: risk factors and treatment implications. J Acquir Immune Defic Syndr 2007;46:456-62
11. Hakim FT, Gress RE. Reconstitution of the lymphocyte compartment after lymphocyte depletion: A key issue in clinical immunology. Eur J Immunol 2005;35:3099-102
12. Li TS, Tubiana R, Katlama C, Calvez V, Ait Mohand H, Autran B. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 1998;351: 1682-6
13. Notermans DW, Pakker NG, Hamann D et al. Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults. J Infect Dis 1999;180: 1050-6
14. Silvestre JF, Albares MP, Ramón R, Botella R. Cutaneous intolerance to tattoos in a patient with human immunodeficiency virus: a manifestation of the immune restoration syndrome. Arch Dermatol 2001;137:669-70
15. Bower M, Nelson M, Young AM et al. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. J Clin Oncol 2005;23:5224-8
16. Vento S, Cainelli F, Mirandola F et al. Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus. Lancet 1996;347:92-3
17. Kudrin A, Chilvers ER, Ginawi A et al. Sarcoid-like granulomatous disease following etanercept treatment for RA. J Rheumatol 2007;34:648-9
18. Verschueren K, Van Essche E, Verschueren P, Taelman V, Westhovens R. Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients. Clin Rheumatol 2007;26:1969-71
19. EI Karoui K, Lanternier F, Brunet A, Blanche P, Guillevin L. Sarcoidosis-like reaction related to propionibacterium acnes and immune restoration syndrome in HIV infection. J Rheumatol 2007;34:2495-6
20. Lenner R, Bregman Z, Teirstein AS, DePalo L. Recurrent pulmonary sarcoidosis in HIV-infected patients receiving highly active antiretroviral therapy. Chest 2001;119:978-81.
21. Powderly WG, Landay A, Lederman MM. Recovery of the immune system with antiretroviral therapy: the end of opportunism? JAMA 1998;280:72-7
22. Shelburne SA 3rd, Hamill RJ, Rodriguez-Barradas MC et al. Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore) 2002;81:213-27
23. Hashimoto K, Yasukawa M, Tohyama M. Human herpesvirus 6 and drug allergy. Curr Opin Allergy Clin Immunol 2003;3:255-60
24. Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol 2007;156:1083-4
25. Shiohara T, Inaoka M, Kano Y. Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses. Allergol Int 2006;55:1-8
26. Kano Y, Shiohara T. The variable clinical picture of druginduced hypersensitivity syndrome (DIHS)_drug rash with eosinophilia and systemic symptoms (DRESS) in relation to the eliciting drug. Immunol Allergy Clin North Am 2009;28:481-501
27. Kano Y, Ishida T, Hirahara K, Shiohara T. Visceral involvements and long-term sequelae in drug-induced hypersensitivity syndrome. Med Clin North Am 2010;94: 743-59
28. Kano Y, Hirahara K, Sakuma K, Shiohara T. Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease. Br J Dermatol 2006;155:301-6
29. Shiohara T, Takahashi R, Kano Y. Drug-induced hypersensitivity syndrome. In: Pichler WJ (ed). Drug Hypersensitivity. Basel: Karger, 2007;251-66
30. Kano Y, Inaoka M, Shiohara T. Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinenia. Arch Dermatol 2004;140:183-8
31. Jevtovic DJ, Salemovic D, Ranin J, Pesic I, Zerjav S, Djurkovic-Djakovic O. The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy. HIV Med 2005;6: 140-3
32. Buchbinder SP, Katz MH, Hessol NA et al. Herpes zoster and human immunodeficiency virus infection. J Infect Dis 1992;166:1153-6
33. Leohloenya R, Meintjes G. Dermatologic manifestations of the immune reconstitution inflammatory syndrome. Dermatol Clin 2006;24:549-70
34. Martínez E, Gatell J, Morán Y et al. High incidence of herpes zoster in patients with AIDS soon after therapy with protease inhibitors. Clin Infect Dis 1998;27:1510-3
35. Tangsinmankong N, Kamchaisatian W, Lujan-Zilbermann J, Brown CL, Sleasman JW, Emmanuel PJ. Varicella zoster as a manifestation of immune restoration disease in HIV-infected children. J Allergy Clin Immunol 2004;113: 742-6
36. Domingo P, Torres OH, Ris J, Vazquez G. Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with human immunodeficiency virus type-1 infection. Am J Med 2001; 110:605-9
37. Morlese JF, Orkin CM, Abbas R et al. Plasma IL-6 as a marker of mycobacterial immune restoration disease in HIV-1 infection. AIDS 2003;17:1411-3
38. Ku CC, Padilla JA, Grose C, Butcher EC, Arvin AM. Tropism of varicella-zoster virus fro human tonsillar CD4 (+) T lymphocytes that express activation, memory, and skin homing markers. J Virol 2002;76:11425-33
39. Ku CC, Zerboni L, Ito H, Graham BS, Wallace M, Arvin AM. Varicella-zoster virus transfer to skin by T cells and modulation of viral replication by epidermal cell interferon-alpha. J ExpMed 2004;200:917-25
40. Mayanja-Kizza H, Jones-Lopez E, Okwera A et al, and Uganda-Case Western Research Collaboration. Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda. J Infect Dis 2005;191:856-65
41. Ramaswamy M, Waters A, Smith C et al. Reconstitution of herpes simplex virus-specific T cell immunity in HIVinfected patients receiving highly active antiretroviral therapy. J Infect Dis 2007;195:410-5
42. Ratnam I, Chiu C, Kandala NB, Easterbrook PJ. Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort. Clin Infect Dis 2006;42:418-27
43. French MA, Lenzo N, John M et al. Immune restoration disease after the treatment of immunodeficient HIVinfected patients with highly active antiretroviral therapy. HIV Med 2000;1:107-15
44. Burgess K, Price P, James IR et al. Interferon-gamma responses to Candida recover slowly or remain low in immunodeficient HIV patients responding to ART. J Clin Immunol 2006;26:160-7
45. Masaki T, Fukunaga A, Tohyama M et al. Human herpes virus 6 encephalitis in allopurinol-induced hypersensitivity syndrome. Acta Derm Venereol 2003;83:128-31
46. Sakuma K, Kano Y, Fukuhara M, Shiohara T. Syndrome of inappropriate secretion of antidiuretic hormone associated with limbic encephalitis in a patient with druginduced hypersensitivity syndrome. Clin Exp Dermatol 2008;33:287-90
47. Chik KW, Chan PK, Li CK et al. Human herpesvirus-6 encephalitis after unrelated umbilical cord blood transplant in children. Bone Marrow Transplant 2002;29:991-4
48. Sissons JG, Carmichael AJ. Clinical aspects and management of cytomegalovirus infection. J Infect 2002;44:78-83
49. Streblow DN, Orloff SL, Nelson JA. Acceleration of allograft failure by cytomegalovirus. Curr Opin Immunol 2007;19:577-82
50. Weigand DA, Burgdorf WH, Tarpay MM. Vasculitis in cytomegalovirus infection. Arch Dermatol 1980;116:1174-6
51. Walker JD, Chesney TM. Cytomegalovirus infection of the skin. Am J Dermatopathol 1982;4:263-5
52. Bhawan J, Gellis S, Ucci A, Chang TW. Vesiculobullous lesions caused by cytomegalovirus infection in an immunocompromised adult. J Am Acad Dermatol 1984;11: 743-7
53. Horn TD, Hood AF. Clinically occult cytomegalovirus present in skin biopsy specimens in immunosuppressed hosts. J AmAcad Dermatol 1989;21:781-4
54. Pariser RJ. Histologically specific skin lesions in disseminated cytomegalovirus infection. J Am Acad Dermatol 1983;9:937-46
55. Lesher JL Jr. Cytomegalovirus infections and the skin. J Am Acad Dermatol 1988;18:1333-8
56. Holland GN. Immune recovery uveitis. Ocular Immunol Inflamm 1999;7:215-21
57. Qazi NA, Morlese JF, Walsh JC, Bunker CB, Francis N, Nelson MR. Severe cutaneous ulceration secondary to cytomegalovirus inclusion disease during successful immune reconstitution with HAART. AIDS Read 2002;12: 452-7
58. Asano Y, Kagawa H, Kano Y, Shiohara T. Cytomegarovirus disease during the course of severe drug eruptions: report of two cases and retrospective study of 18 patients with drug-induced hypersensitivity syndrome. Arch Dermatol 2009;145:1030-6
59. Daudén E, Fernández-Buezo G, Fraga J, Cardenoso L, García-Díez A. Mucocutaneous presence of cytomegalovirus associated with human immunodeficiency virus infection: discussion regarding its pathogenetic role. Arch Dermatol 2001;137:443-8
60. Marais S, Wilkinson RJ, Pepper DJ, Meintjes G. Management of patients with the immune reconstitution inflammatory syndrome. Curr HIV_AIDS Rep 2009;6:162-71
61. Aota N, Shiohara T. Viral connection between drug rashes and autoimmune diseases: how autoimmune re sponses are generated after resolution of drug rashes. Autoimmun Rev 2009;8:488-94
62. Aota N, Hirahara K, Kano Y, Fukuoka T, Yamada A, Shiohara T. Systemic lupus erythematous presenting with Kikuchi-Fujimoto's disease as a long-term sequela of drug-induced hypersensitivity syndrome. A possible role of Epstein-Barr virus reactivation. Dermatology 2009;218: 275-7
63. Intalapaporn P, Poovorawan Y, Suankratay C. Immune reconstitution syndrome associated with parvovirus B19- induced pure red cell aplasia during highly active antiretroviral therapy. J Infect 2006;53:e79-82
64. Garcia Vidal C, Rodríguez Femández S, Martínez Lacasa J et al. Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis. Clin Infect Dis 2005;40:756-9
65. Arend SM, Leyten EM, Franken WP, Huisman EM, van Dissel JT. A patient with de nove tuberculosis during antitumor necrosis factor-alpha therapy illustrating diagnostic pitfalls and paradoxical response to treatment. Clin Infect Dis 2007;45:1470-5
66. Belknap R, Reves R, Burman W. Immune reconstitution by Mycobacterium tuberculosis after discontinuing infliximab. Int J Tuberc Lung Dis 2005;9:1057-8
67. Mirmirani P, Maurer TA, Herndier B, McGrath M, Weinstein MD, Berger TG. Sarcoidosis in a patient with AIDS: a manifestation of immune restoration syndrome. J Am Acad Dermatol 1999;41:285-6
68. Co DO, Hogan LH, II-Kim S, Sandor M. T cell contributions to the different phases of granuloma formation. Immunol Lett 2004;92:135-42.